Cargando…
Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect—except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotens...
Autor principal: | Haaland, Kirsti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452282/ https://www.ncbi.nlm.nih.gov/pubmed/20063032 http://dx.doi.org/10.1007/s10194-009-0182-7 |
Ejemplares similares
-
Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011) -
Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
por: Wegleiter, K., et al.
Publicado: (2018) -
Prenatal hypocalvaria after prolonged intrauterine exposure to
angiotensin II receptor antagonists
por: Lallemant, Marine, et al.
Publicado: (2018) -
The angiotensin II type 1 receptor blocker valsartan in the battle against COVID‐19
por: de Ligt, Marlies, et al.
Publicado: (2021) -
Spectrofluorimetric method for determination of some angiotensin II receptor antagonists
por: El-Shaboury, Salwa R., et al.
Publicado: (2012)